🇮🇳
National
🔴 High
QDENGA — India's First Dengue Vaccine
📅 Published 22 Jul 2026 · July 2026
QDENGA — India's First Dengue Vaccine
India approved QDENGA (TAK-003) as its first dengue vaccine after DCGI clearance.
Key facts
- Manufacturer: Takeda Biopharmaceuticals India
- Age group: 4–60 years
- Type: Live-attenuated tetravalent vaccine
- Covers: DENV-1, DENV-2, DENV-3, DENV-4
- Dosage: 2 subcutaneous doses
- Interval: 3 months
- WHO prequalified
Prelims favourite:
QDENGA → Dengue → tetravalent → 4 serotypes → 2 doses → 3 months.
📝 Relevant Exams:
UPSC